Thrombolytic therapies with plasminogen activators (t-PA, SK and UK) have high potential in treating thrombosis, facilitating the use of plasminogen activators in medicine today, but their high prices and side effects limit their wide application. Here, PLAT is linked to deep vein thrombosis.